These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 24824274)

  • 1. Tigecycline minimum inhibitory concentration for carbapenem-resistant Acinetobacter baumannii by two methods.
    Wang R; Wang H; She D
    Chin Med J (Engl); 2014; 127(10):1997. PubMed ID: 24824274
    [No Abstract]   [Full Text] [Related]  

  • 2. Mutant prevention concentration of tigecycline for carbapenem-susceptible and -resistant Acinetobacter baumannii.
    Cui JC; Liu YN; Chen LA
    J Antibiot (Tokyo); 2010 Jan; 63(1):29-31. PubMed ID: 19911030
    [No Abstract]   [Full Text] [Related]  

  • 3. In vitro activities of tigecycline alone and in combination with colistin sulfate or sulbactam against carbapenem-susceptible and -resistant Acinetobacter baumannii strains isolated from Intensive Care Units.
    Ozbek B; Otük G
    Int J Antimicrob Agents; 2010 Aug; 36(2):191-2. PubMed ID: 20537868
    [No Abstract]   [Full Text] [Related]  

  • 4. In vitro activities of carbapenem/sulbactam combination, colistin, colistin/rifampicin combination and tigecycline against carbapenem-resistant Acinetobacter baumannii.
    Song JY; Kee SY; Hwang IS; Seo YB; Jeong HW; Kim WJ; Cheong HJ
    J Antimicrob Chemother; 2007 Aug; 60(2):317-22. PubMed ID: 17540672
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In vitro Activity of Colistin in Combination with Tigecycline against Carbapenem-Resistant Acinetobacter baumannii Strains Isolated from Patients with Ventilator-Associated Pneumonia.
    Cikman A; Gulhan B; Aydin M; Ceylan MR; Parlak M; Karakecili F; Karagoz A
    Int J Med Sci; 2015; 12(9):695-700. PubMed ID: 26392806
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In vitro synergistic activity of colistin with tigecycline or β-lactam antibiotic/β-lactamase inhibitor combinations against carbapenem-resistant Acinetobacter baumannii.
    Karaoglan I; Zer Y; Bosnak VK; Mete AO; Namiduru M
    J Int Med Res; 2013 Dec; 41(6):1830-7. PubMed ID: 24265334
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of Minocycline Susceptibility Testing Methods for Carbapenem-Resistant Acinetobacter baumannii.
    Wang P; Bowler SL; Kantz SF; Mettus RT; Guo Y; McElheny CL; Doi Y
    J Clin Microbiol; 2016 Dec; 54(12):2937-2941. PubMed ID: 27629901
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In vitro activities of various antimicrobials alone and in combination with tigecycline against carbapenem-intermediate or -resistant Acinetobacter baumannii.
    Scheetz MH; Qi C; Warren JR; Postelnick MJ; Zembower T; Obias A; Noskin GA
    Antimicrob Agents Chemother; 2007 May; 51(5):1621-6. PubMed ID: 17307973
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Minocycline and Tigecycline: What Is Their Role in the Treatment of Carbapenem-Resistant Gram-Negative Organisms?
    Shankar C; Nabarro LEB; Anandan S; Veeraraghavan B
    Microb Drug Resist; 2017 Jun; 23(4):437-446. PubMed ID: 27564414
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Role of tigecycline in the control of a carbapenem-resistant Acinetobacter baumannii outbreak in an intensive care unit.
    Jamal W; Salama M; Dehrab N; Al Hashem G; Shahin M; Rotimi VO
    J Hosp Infect; 2009 Jul; 72(3):234-42. PubMed ID: 19493588
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [In vitro activity of tigecycline against multiple resistant Acinetobacter baumannii and carbapenem resistant Klebsiella pneumoniae isolates].
    Arikan Akan O; Uysal S
    Mikrobiyol Bul; 2008 Apr; 42(2):209-15. PubMed ID: 18697418
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparative in vitro activity of minocycline and selected antibiotics against carbapenem-resistant Acinetobacter baumannii from Thailand.
    Thamlikitkul V; Tiengrim S; Seenama C
    Int J Antimicrob Agents; 2016 Jan; 47(1):101-2. PubMed ID: 26725031
    [No Abstract]   [Full Text] [Related]  

  • 13. Antimicrobial susceptibility patterns of multidrug-resistant Pseudomonas aeruginosa and Acinetobacter baumannii against carbapenems, colistin, and tigecycline.
    Somily AM; Absar MM; Arshad MZ; Al Aska AI; Shakoor ZA; Fatani AJ; Siddiqui YM; Murray TS
    Saudi Med J; 2012 Jul; 33(7):750-5. PubMed ID: 22821309
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In-vitro activity of tigecycline against clinical isolates of Acinetobacter baumannii in Taiwan.
    Liu JW; Wang LS; Cheng YJ; Hsu GJ; Lu PL; Liu YC; Chen CM; Lee CM; Sun W; Jang TN; Chiang PC; Chuang YC; Lin HC; Shi ZY; Kung HC; Huang CH; Tsao SM; Lu CT; Liao CH; Hsueh PR
    Int J Antimicrob Agents; 2008 Nov; 32 Suppl 3():S188-91. PubMed ID: 19013353
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In Vitro Activity of Eravacycline against Carbapenem-Resistant Enterobacteriaceae and Acinetobacter baumannii.
    Livermore DM; Mushtaq S; Warner M; Woodford N
    Antimicrob Agents Chemother; 2016 Jun; 60(6):3840-4. PubMed ID: 27044556
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In vitro activity of tigecycline against multidrug-resistant Acinetobacter baumannii.
    Capone A; D'Arezzo S; Visca P; Petrosillo N;
    J Antimicrob Chemother; 2008 Aug; 62(2):422-3. PubMed ID: 18424790
    [No Abstract]   [Full Text] [Related]  

  • 17. Efficacy of sulbactam and its combination with imipenem, colistin and tigecycline in an experimental model of carbapenem-resistant Acinetobacter baumannii sepsis.
    Dinc G; Demiraslan H; Elmali F; Ahmed SS; Metan G; Alp E; Doganay M
    Chemotherapy; 2013; 59(5):325-9. PubMed ID: 24525528
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In vitro activity of tigecycline against clinical isolates of Acinetobacter baumannii and Stenotrophomonas maltophilia.
    Insa R; Cercenado E; Goyanes MJ; Morente A; Bouza E
    J Antimicrob Chemother; 2007 Mar; 59(3):583-5. PubMed ID: 17213264
    [No Abstract]   [Full Text] [Related]  

  • 19. Contribution of the TetB Efflux Pump to Minocycline Susceptibility among Carbapenem-Resistant Acinetobacter baumannii Strains.
    Wang P; McElheny CL; Mettus RT; Shanks RMQ; Doi Y
    Antimicrob Agents Chemother; 2017 Oct; 61(10):. PubMed ID: 28739789
    [No Abstract]   [Full Text] [Related]  

  • 20. Rapid development of Acinetobacter baumannii resistance to tigecycline.
    Reid GE; Grim SA; Aldeza CA; Janda WM; Clark NM
    Pharmacotherapy; 2007 Aug; 27(8):1198-201. PubMed ID: 17655518
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.